Next Generation Wound Care Products for the World
Clinical IV Poster 504 was awarded Best in Category for Wounds using BloodSTOP iX at 51st Annual Meeting of the American Burn Association!
BloodSTOP iX creates a buzz at ABA Conference! LSP attended the 51stAnnual Meeting of the American Burn Association on April 2-5, 2019, with intent to showcase BloodSTOP iX Hemostasis Dressing in this burn specialty. Through our continued support to John...
A World of Opportunities LSP held its International Sales Meeting at the Dolce Hayes Mansion Hotel and Resort on July 29th, 2018. The goal of this meeting was to create an environment for Medical Practitioners, International Distributors, and US Sales...
We are pleased to announce that LifeScience Plus will attend and exhibit BloodSTOP iX Hemostasis and WoundCare Dressing at the 12th Asia Pacific (AP) Burn Congress in Singapore. Dr. Stathis Poulakidas (Chairman Director of Cook County Health Burn Center, Chicago, IL, USA) will be lecturing on Aug. 15, 2019 on the hemostatic and healing power of BloodSTOP iX on debridement and graft donor sites in burn surgery. Additionally, two abstracts on his Cook County Burn Center studies have been submitted for further podium speaking engagement.
You are welcome to visit us at this event, meet Dr. Poulakidas and his team, and hear directly from them the outstanding results in both hemostasis and healing in the treatment of burns with BloodSTOP iX.
Over the last 6 months I had numerous opportunities to evaluate the hemostatic properties of BloodSTOP® iX and to compare it to a number of similar products available in the surgical market place.
This product was successfully used for control of epistaxis (both anterior and posterior), postoperative hemostasis following sinus surgery and postoperative hemostasis/artificial barrier following adult tonsillectomy.
BloodSTOP® iX was simple to use, less expensive than other hemostatic products and was well tolerated by the patients. In my experience, there were no complications related to the use of the product. No surgical site infections were observed.
Who We Are
LifeScience PLUS is a medical device company committed to developing and marketing innovative technology in hemostasis (stop bleeding) and wound healing. Our best-in-class portfolio of BloodSTOP® products are revolutionizing the way acute and chronic injuries wounds are managed.
Applications for this technology are numerous. Our primary focus is in the medical/hospital environment during surgical procedures and for emergency medicine. Other applications include dentistry, military, consumer and veterinary medicine.
These products are covered by U.S. Patent No. 7,262,181
The BloodSTOP® product family is at the forefront of a new generation of wound care products for medical and dental industries that are not only more practical to administer but also more effective and palliative for the patient.
BloodSTOP® and BloodSTOP® iX are biocompatible, non-irritating, woven matrices of fibers made from natural plant compounds. They adhere to a wound, initiate blood coagulation, stop bleeding, and form a protective membrane layer to create an optimal environment for wound healing. Their water solubility allows for removal by rinsing, without disruption of a clotted surface.
Our life-saving technology is being used on the battlefield to treat hemorrhaging wounds, which remain a leading cause of death on the battlefield. Pre-Clinical Trial Shows BloodSTOP® iX Battle Matrix Has 100% Survival Rate in Military Standard Test of Traumatic Bleeding.
We are committed to helping military personnel all over the world.
BloodSTOP® hemostatic products are safe and effective for wound care for all the large and small animals that a veterinarian is likely to encounter. BloodSTOP® and BloodSTOP® iX can be used to stop bleeding in cases of minor lacerations or more significant wound trauma.
BloodSTOP® hemostats can be administered for household pets, and by farmers and ranchers to treat cuts, lacerations, and wounds on livestock and horses for both operations and wound care.